NMPA Approval

Linezolid and Sodium Chloride Injection

Approval Number

国药准字H20234142

Company江苏吴中医药集团有限公司苏州制药厂

Registration Date

September 12, 2023

Drug Information

Generic Name

利奈唑胺氯化钠注射液

Dosage Form

注射剂

Strength

300ml：利奈唑胺0.6g与氯化钠2.7g

Drug Type

化学药品

Registration Date

September 12, 2023

Company Information

Applicant Company

Company Name江苏吴中医药集团有限公司苏州制药厂

Company Address

苏州市吴中区东吴南路2-1号

Manufacturing Company

Company Name江苏大红鹰恒顺药业有限公司

Company Address

江苏省沭阳经济技术开发区宁波路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

利奈唑胺氯化钠注射液 - NMPA 批准文号 | MedPath